Concord Medical Services (NYSE:CCM) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Concord Medical Services Holdings Limited (NYSE:CCM) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.17 and traded as high as $4.77. Concord Medical Services shares last traded at $4.69, with a volume of 43,786 shares.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Concord Medical Services Trading Down 4.3%

The company has a 50 day simple moving average of $4.55 and a 200 day simple moving average of $4.19. The company has a debt-to-equity ratio of 1.33, a current ratio of 0.48 and a quick ratio of 0.46.

Concord Medical Services (NYSE:CCM) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.